3 results
To demonstrate the safety and effectiveness of the Tryton Side Branch Stent* with main branch approved DES compared to side branch balloon angioplasty and main branch approved DES in the treatment of de novo native coronary artery bifurcation…
Primary Objectives:* To compare overall survival (OS) of patients who receive NKTR-102given once every 21 days (q21d) to patients who receive Treatment ofPhysician*s Choice (TPC) selected from the following list of seven singleagentintravenous…
To assure the continued safety and effectiveness of the Tryton Side Branch Stent* with main branch approved DES in the treatment of de novo native coronary artery bifurcation lesions with side branch diameter ranging from >=2.5 mm to <…